Companies: 10,795·Total market cap: $144.5T
Oncternal Therapeutics, Inc.

Oncternal Therapeutics, Inc.

ONCTNASDAQHealthcare
$0.53
$-0.17(-24.12%)
Market Cap$1558546
P/E Ratio—
52W High$10.613
52W Low$0.5266
SEC Filings

Oncternal Therapeutics, Inc. (ONCT) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001260990 · ONCT · NASDAQ · as of Jun 9, 2026

Filing snapshot

1,007+
Total Filings
EFFECT
Latest Form
2025-03-31
Most Recent
2004
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001260990 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2024-03-07
Fiscal Year End
Mar 7, 2024
Accession No.
0000950170-24-027984
Primary Document
onct-20231231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001260990 · Accession 0000950170-24-027984

Latest Key Filings

10-QQuarterly Report
10-Q
2024-11-06
View 10-Q on SEC
8-KCurrent Report
8-K
2024-11-25Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
EFFECTEFFECT
EFFECT
2025-03-31
View
EFFECTEFFECT
EFFECT
2025-03-31
View
EFFECTEFFECT
EFFECT
2025-03-31
View
EFFECTEFFECT
EFFECT
2025-03-31
View
EFFECTEFFECT
EFFECT
2025-03-31
View
EFFECTEFFECT
EFFECT
2025-03-31
View
15-12G15-12G
15-12G
2025-03-27
View
S-8 POSS-8 POS
S-8 POS
2025-03-27
View
S-8 POSS-8 POS
S-8 POS
2025-03-27
View
S-8 POSS-8 POS
S-8 POS
2025-03-27
View
S-8 POSS-8 POS
S-8 POS
2025-03-27
View
S-8 POSS-8 POS
S-8 POS
2025-03-27
View
S-8 POSS-8 POS
S-8 POS
2025-03-27
View
S-8 POSS-8 POS
S-8 POS
2025-03-27
View
S-8 POSS-8 POS
S-8 POS
2025-03-27
View
Showing 1–15 of 512 filingsForm 4 / 144 hidden· 1007 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001260990  |  Exchange: NASDAQ · Healthcare

Oncternal Therapeutics, Inc. (NASDAQ: ONCT) has submitted 1,007+ documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2004. As a Healthcare sector company with CIK 0001260990, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Oncternal Therapeutics, Inc.'s most comprehensive regulatory disclosure. The most recent Oncternal Therapeutics, Inc. 10-K was filed on 2024-03-07 for fiscal year ending 2024. Historical ONCT 10-K annual reports are available from 2010 through 2024.

Investors researching Oncternal Therapeutics, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
ASLN SEC Filings →VBIV SEC Filings →PTE SEC Filings →CMAX SEC Filings →AVGR SEC Filings →SAVAW SEC Filings →NBSE SEC Filings →CWBR SEC Filings →
→ ONCT Financials→ ONCT Earnings→ ONCT Insider Trades

Frequently Asked Questions

ONCT SEC Filings · 8 questions

Oncternal Therapeutics, Inc. (ONCT) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 1,007+ filings and access original documents at no cost. Oncternal Therapeutics, Inc.'s CIK is 0001260990.

ONCT SEC filingsOncternal Therapeutics, Inc. SEC documentsfind ONCT 10-K